Clinical Trial Update: Clofarabine-cyclophosphamide as Salvage Therapy for Refractory and Relapsed Acute Lymphoblastic Leukemia (ALL) Adults [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of clofarabine and cyclophosphamide as salvage therapy for adults with refractory or relapsed acute lymphoblastic leu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Clolar (Clofarabine)
• Cytoxan (cyclophosphamide)

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2019-01-25